Abstract
Introduction
Policy interventions to reduce racial/ethnic cigarette smoking and related health disparities are needed to improve health equity. Simulation models can be useful in gauging the impact of tobacco control policies on trends in smoking-related outcomes, but few have systematically analyzed the impact of tobacco control policies across racial/ethnic groups.
Methods
We developed 3 separate SimSmoke models for the non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic populations. Following a first-order Markov process, population projections evolve through net immigration and death rates, and smoking prevalence evolves through initiation, cessation, and relapse. The models incorporate policies implemented from 2011 to 2023 and are used to consider trends in NHW, NHB, and Hispanic smoking prevalence and smoking-attributable death and the impact of policies on those trends.
Results
The models indicate major differences in smoking trends and smoking-attributable deaths (SADs) among NHW, NHB, and Hispanic adults, with NHB males experiencing the smallest smoking decline through 2023 and having the highest 2023 smoking prevalence. The models predict major differences in the impact of tobacco control policies, especially the greater effect of cigarette taxes on NHB and Hispanic adults than NHW adults and the reduced impact of T21 laws on NHB compared to NHW and Hispanic adults.
Discussion
The models predict large differences in levels and rates of decline in NHW, NHB, and Hispanic smoking prevalence, leading to widening health disparities between racial/ethnic groups. Further study is needed on differential race/ethnicity impacts of tobacco control policies and the role of cigars, e-cigarettes, and other product use.
Introduction
Despite decreasing cigarette use in the United States since the mid-1900s,1 smoking disparities are common.2 Disparities by race/ethnicity in cigarette smoking prevalence, smoking initiation and cessation, and downstream health consequences are complex. For example, American Indian and Alaskan Native (AI/AN) populations consistently have the highest smoking prevalence, with non-Hispanic Black (NHB) and non-Hispanic White (NHW) adults smoking cigarettes at similar rates.2-4 Cigarette smoking initiation is highest among AI/AN populations, and cessation is lowest among AI/AN and NHB populations.2,3,5 From 2016 to 2020, cancer mortality was highest among the AI/AN followed by NHB, NHW, and Hispanic populations, while cancer incidence was highest for Black males.6 Identifying policy interventions to reduce racial/ethnic disparities in cigarette smoking and related health outcomes is needed to improve health equity.
Tobacco control policies have been effective tools in reducing cigarette smoking outcomes in the broader population.7-17 Most studies find that minimum legal sales age laws, such as Tobacco 21 (T21),18-25 cigarette taxes,26-43 smoke-free air laws,26,35,37,38,43-55 and media campaigns,45,56-65 reduce cigarette smoking prevalence, initiation, and cessation. While studies call for consideration of the equity impact of tobacco control policies,8,9,12,14-17,66 the limited evidence indicates that the policy impacts on persistent racial/ethnic smoking disparities are largely ineffective.19,20,24,26,33,34,39,41,52,58,61,64,65,67-81 The richest literature on cigarette tax policies does indicate that higher taxes may be more effective in curbing smoking outcomes among NHB and Hispanic adults than NHW adults.26,33,34,39,70-73 Heterogeneity in settings, context, measures, and populations complicates the conclusions drawn from evaluations of the impact of smoke-free air laws and media campaigns on racial/ethnic smoking disparities.17
Simulation models, such as SimSmoke,82-87 can be useful in gauging the impact of past and potential future tobacco control policies on variations in racial/ethnic smoking-related outcomes.88 For example, menthol cigarette use among the NHB population may explain their later smoking initiation and lower smoking intensity but similar or higher smoking rates and higher tobacco-related mortality at older ages.89 Simulations of the impact of menthol cigarette bans have found that menthol cigarette use was overrepresented among NHB adults, and menthol use was partially responsible for tobacco-related smoking disparities.90-93 A menthol cigarette ban is projected to reduce smoking prevalence by 9.7% and avert 633 252 smoking-attributable deaths (SADs) in the overall population by 2050,94 but reduce smoking prevalence by 24.8% and avert 237 317 SADs among NHB adults alone.92 Otherwise, simulation models have not been used to estimate the role of policies in reducing racial/ethnic smoking and health disparities.88,95,96
We develop separate US SimSmoke tobacco control simulation models85,87,97-99 for NHW, NHB, and Hispanic adults to project trends in smoking prevalence and smoking-attributable mortality among these groups and the impact of policies on these trends. We compare model outcomes to recent smoking trends. The difference between the model and survey estimators from 2014 to 2018 is used to explain the implicit impact of ENDS and other omitted factors, a method previously employed using US,87 England,100 and Canada101 SimSmoke models. Building on prior work,87 we also distinguish the impact of tobacco control policies for each racial/ethnic group on smoking prevalence and SADs.
Methods
Because data are limited for AI/AN and Asian populations, we consider only the NHW, NHB, and Hispanic populations. We develop 3 separate SimSmoke models for these populations, each with individual components for population, cigarette smoking prevalence, tobacco control policies, and SADs.
The models start in 2006, a year of relative stability for tobacco control policies and smoking prevalence. Starting in 2006 also provided sufficient years for model calibration and validation. Populations are distinguished by age and sex and further differentiated by current-, former-, and never-smoking status. Assuming a first-order Markov process, population projections evolve through net immigration and death rates, and smoking prevalence evolves through initiation, cessation, and relapse as impacted by policies implemented through 2023.
Data
Using demographic data from the US Census Bureau and the Centers for Disease Control and Prevention (see Appendix S1),102 we started with the population in 2006, and in future years applied mortality rates in 2006-2060, and estimated net immigration rates by age, sex, and race/ethnicity to predict population in 2007-2060. Mortality rates were distinguished by age, sex, and race/ethnicity using actual rates for 1999-2019 and projected rates for 2020-2060. Mortality rates of NHW, NHB and Hispanic adults were further distinguished by smoking status using yearly data from CISNET (see Appendix S1).103-105 Net immigration rates were estimated by the ratio of net immigrants to the total population for NHW, Black alone (NHB rates were not available from the US Census Bureau), and Hispanic by age and sex. This ratio was averaged over 2017-2019 by age, sex, and racial/ethnic group and applied to all years. The models well approximate population trends (see Appendix S2).
The model distinguishes the 2006 baseline year population for each racial/ethnic group into never, current, and former smoking status. Smoking prevalence by race/ethnicity, 7 age groups (18-24, 25-34, 35-44, 45-54, 55-64, 65-74, 75+), and sex were obtained from the 2006/7 Tobacco Use Supplement (TUS) of the Current Population Survey (CPS), a large-scale, nationally-representative survey. Current smoking status is defined as smoking more than 100 cigarettes lifetime and currently smoking either daily or some days. Former smoking status is defined as having smoked more than 100 cigarettes but not currently smoking, and is distinguished into 17 subgroups as “quit less than 1 year,” “quit at least 1 year but less than 2 years,” through “quit more than 15 years.”
The 2006/7 TUS-CPS smoking prevalence by 7 age groups and sex were first linearly interpolated to single ages and smoothed using a moving average (MA-3), yielding differences by age and sex group between the initial survey and 2006 prevalence estimates. We further adjusted by race/ethnicity, sex, and 4 age groups (18-24, 25-44, 45-64 and 65+, but not all adults age 18 and above) using the ratio of the 2006 TUS-CPS to the initial 2006 model prevalence. Thereby, the model starts at the same prevalence by sex and age group as the 2006 TUS-CPS.
SimSmoke models generally set the last age of male and female smoking initiation at 1 year before reaching the maximum smoking prevalence in 2006. SimSmoke applies smoking cessation rates for after the last age of net initiation. Cessation rates are measured as the percentage that quit smoking within the last 3-12 months among those who smoked 12 months ago, where those quitting in the last 3 months offset former smokers who quit in the previous 3-12 months but subsequently relapse.82-86 Cessation rates are distinguished by racial/ethnic group as suggested by recent studies.106-108 After cessation in the first year, relapse occurs among adults who quit smoking at least 12 months ago. The model applies the same (non-race specific) relapse rates by age, sex, and years since quit to each racial/ethnic group due to mixed evidence of differential relapse rates after the first year quit.109-112 The formulas and the measure of net initiation are provided in Appendix S3.
Policy effects
The SimSmoke model includes separate modules for cigarette prices (taxes), smoke-free air laws, mass media campaigns, marketing restrictions, cessation treatments, and youth access (T21) policies. Policy effects are estimated in terms of the percentage change in smoking rates relative to initial rates [(post-policy rate—initial rate)/initial rate]. When a policy change is implemented, the immediate PC effect is applied to smoking prevalence in year t. In the following years, SimSmoke applies a percentage reduction to the initiation rate and a percentage increase to the cessation rate. When more than one policy is implemented, multiplicative effects are applied, ie, (1+PCi) *(1+PCj) for policies i and j. Table 1 provides policy descriptions and effect sizes.
Table 1.
Tobacco control policies, specifications, and effect sizes applied in SimSmoke race models.
| Policy | Description | Policy effect size |
|---|---|---|
| Cigarette excise taxes | ||
| Cigarette price/tax | The effect of taxes is directly incorporated through the average price after tax. The price elasticity is used to convert the price changes (%) into effect sizes. | Elasticities |
| −0.4 for ages 14-17 | ||
| −0.3 for ages 18-24 | ||
| −0.2 for ages 25-34 | ||
| −0.1 for ages 35-64 | ||
| −0.2 for ages 65+ | ||
| Smoke-free air laws | ||
| Worksite smoking ban | Ban in all indoor worksites, with strong enforcement of laws (reduced 1/3 if allowed in ventilated areas and 2/3 if allowed in common areas) | −6% prevalence and initiation, +6% cessation |
| Restaurant smoking ban | Ban in all indoor restaurants (scaled for lower coverage), with strong enforcement of laws | −2% prevalence and initiation, +2% cessation |
| Pubs and bars smoking ban | Ban in all indoor in pubs and bars (scaled for lower coverage), with strong enforcement of laws | −1% prevalence and initiation, +1% cessation |
| Other place bans | Ban in 3 out of 4 government buildings (scaled for lower coverage), retail stores, public transportation, and elevators, with strong enforcement of laws | −1% prevalence and initiation, +1% cessation |
| Enforcement and publicity | Government agency enforces the laws and publicity via tobacco control campaigns | Effects reduced 50% absent publicity and enforcement |
| Media campaigns | ||
| High level | Campaign publicized heavily with state and local programs with strong funding (>$0.50 USD) | −6.5% prevalence and initiation, +6.5% cessation |
| Medium level | Campaign publicized with funding of at least $0.10 USD per capita | −3.25% prevalence and initiation, +3.25% cessation |
| Low-level media | Campaign publicized only sporadically with minimal funding (<$0.10 USD per capita) | −1.63% prevalence and initiation, +1.63% cessation |
| Marketing restrictions | ||
| Comprehensive | Ban on all forms of direct advertising including point of sale and indirect marketing | −5% prevalence, |
| −8% initiation, | ||
| +4% cessation | ||
| Moderate | Ban on broadcast media, newspapers, and billboards marketing and at least some indirect marketing (sponsorship, branding, giveaways) | −3% prevalence, |
| −4% initiation, | ||
| +2% cessation | ||
| Minimal | Ban on broadcast media advertising | −1% prevalence and −1% initiation only |
| Enforcement | Government agency enforces the laws | Reduced 50% absent enforcement |
| Cessation treatment policies | ||
| Availability of pharmacotherapies | Legality of nicotine replacement therapy and/or Bupropion and Varenicline | −1% prevalence, |
| +4% cessation | ||
| Cessation treatment financial coverage | Payments to cover pharmacotherapy and behavioral cessation treatment with high publicity (reduced 12.5% for moderate and 18.75% for low publicity) | −2.25% prevalence, |
| +8% cessation | ||
| Quitline | Three quit line types: passive, proactive, and active with follow-up. (Effect size reduced by 1/3 if quit line is proactive, reduced by 2/3 if quit line passive.) | −1% prevalence, |
| +6% cessation | ||
| Brief interventions | Advice by healthcare provider to quit and advice on treatment | −1% prevalence, |
| +6% cessation | ||
| All cessation policies combined | Complete availability and reimbursement of pharmaco- and behavioral treatments, quitlines, and brief interventions | −5.68% prevalence, |
| +29.4% cessation | ||
| Youth access policies | ||
| Strong enforcement, well publicized | Compliance checks conducted 4 times per year per outlet, penalties are potent and enforced with heavy publicity | −16% for ages 16-17 and −24% for ages 10-15 |
| Moderate enforcement with some publicity | Compliance checks conducted regularly, penalties are potent, and publicity and merchant training are included | −8% initiation and prevalence for ages 16-17 and −12% for ages 10-15 |
| Law enforcement | Compliance checks are conducted sporadically, penalties are weak | −2% initiation and prevalence for ages 16-17 and −3% ages 10-15 |
| Tobacco 21 policy | ||
| T21 laws coverage | State-level laws coverage with moderate compliance checks | −30% prevalence for ages 18-20 and −15% for ages 16-17, and −30% initiation for all ages under 21 |
Unless otherwise indicated, the effects are in terms of the reduction in prevalence during the first year with continuing impacts on initiation and cessation rates in future years. Only the effects of cigarette prices differed by race/ethnicity in the best estimation, with a 1:2:2 ratio for NHW/NHB/Hispanic, implying multipliers of 0.76/1.52/1.52 (see Appendix S4).
Policy effects from previous US SimSmoke models85,87-99 are applied to each racial/ethnic model. Based on previous reviews10,12,17 and our literature review of more recent evaluations (see Appendix S4), differential policy effects by race/ethnicity were not well distinguished for Tobacco 21, cessation treatment, health warnings, mass media campaigns, and smoke-free-air laws. Only cigarette price was estimated to have differential effects by race/ethnicity, with a 1:2:2 ratio for NHW/NHB/Hispanic populations applied to the cigarette price elasticities in Table 1 (see Appendix S4).
Calibration
Each racial/ethnic subgroup model was calibrated by age and sex by adjusting initiation, cessation, and relapse rates based on differences in the model projected 2006-2010 relative reduction in smoking prevalence compared to the TUS-CPS estimated 2006-2010 relative reduction, eg, if the SimSmoke relative reduction is greater than the TUS-CPS relative reduction, we increased net initiation rates at younger ages or decreased cessation rates at older ages. Since the Hispanic model after the calibration by 2010 exhibited an increasing pattern for male prevalence at ages 18-24 (contradicting our expectation and the survey decreasing pattern in 2010-2014 as well) and an unexpectedly large reduction for female prevalence at ages 65 and above for future years, we re-calibrated the Hispanic model only for those 2 age and sex groups. We re-calibrated the model by considering the relative reduction in 2006-2014 (the next available TUS-CPS survey after 2010, but before significant ENDS use) so that the relative reduction in 2006-2010 smoking prevalence was near the average relative reduction from the 2006-2010 TUS-CPS and half the relative reduction in 2006-2014. A more detailed description of the methods and results is provided in Appendix S5.
Analysis of outcomes
Four types of analysis were conducted. First, we predicted short-term trends in smoking prevalence by age, sex, and race/ethnicity in 2006-2023. Second, we compared the relative changes in smoking prevalence by age, sex, and race/ethnicity from SimSmoke to that of 2006-2018 TUS-CPS. A third analysis estimated the impact of cigarette-oriented policies from 2006 to 2023 in reducing NHW, NHB, and Hispanic smoking prevalence, where the relative changes in smoking prevalence incorporating specific policies are compared to the relative changes in smoking prevalence under a counterfactual with policies maintained at 2006 levels.
Our final analysis pertains to SADs and life year lost (LYLs) health impacts by race/ethnicity. SADs by age, sex, and race/ethnicity are calculated by first multiplying the number of adults who currently smoke at each age by their excess (no. currently smoke−no. never smoke) mortality risks. We applied the same procedure to adults who formerly smoked and summed over the number of adults who currently and formerly smoked to obtain total SADs.85 We calculated LYLs as the product of SADs and life expectancy.102 LYLs show a greater loss among younger than older adults.87 To gauge disparities, we calculated per capita SADs and LYLs. Since SADs occur almost exclusively after age 40, we measured per capita SADs and LYLs as 2023 SADs and LYLs for each race/ethnicity divided by their respective 2022 population at ages 40+.
Results
Smoking levels and trends projected by SimSmoke
Tables 2-4 show SimSmoke results for adult NHW, NHB, and Hispanic smoking prevalence by age and sex from 2006 to 2023. For ages 18 and above, the 2006 male (female) smoking prevalence was 21.9% (18.7%) for NHW, 21.2% (14.9%) for NHB, and 16.2% (9.1%) for Hispanic adults, with relative reductions from 2006 to 2023 of 37.5% (36.2%) for NHW, 25.2% (35.8%) for NHB, and 42.6% (41.8%) for Hispanic adults.
Table 2.
Smoking prevalence of NHW adults and percent changes in SimSmoke and TUS-CPS, by age and sex, 2006-2023.
| Sex | Ages | Source | 2006 | 2010 | 2018 | 2023 | % change 2006-2010 | % change 2010-2018 | Difference % change 2010-2018 | % change 2006-2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Male | 18 and above | SimSmoke | 21.9% | 19.1% | 15.6% | 13.7% | −12.9% | −18.4% | 10.2% | −37.5% |
| TUS-CPS | 21.5% | 18.9% | 13.5% | −12.3% | −28.6% | |||||
| 18-24 | SimSmoke | 27.1% | 23.3% | 21.2% | 18.1% | −13.9% | −8.9% | 48.2% | −33.0% | |
| TUS-CPS | 27.1% | 23.3% | 10.0% | −13.9% | −57.1% | |||||
| 25-44 | SimSmoke | 25.7% | 22.6% | 18.5% | 16.7% | −12.3% | −18.2% | 10.5% | −35.2% | |
| TUS-CPS | 25.7% | 22.6% | 16.1% | −12.3% | −28.7% | |||||
| 45-64 | SimSmoke | 22.5% | 19.8% | 15.7% | 13.7% | −12.2% | −20.7% | 0.2% | −39.1% | |
| TUS-CPS | 22.5% | 19.8% | 15.6% | −12.2% | −20.9% | |||||
| 65 and above | SimSmoke | 9.4% | 8.9% | 8.9% | 8.4% | −5.2% | 0.1% | 7.3% | −9.9% | |
| TUS-CPS | 9.4% | 8.9% | 8.3% | −5.1% | −7.2% | |||||
| Female | 18 and above | SimSmoke | 18.7% | 16.4% | 13.5% | 12.0% | −12.5% | −17.6% | 9.3% | −36.2% |
| TUS-CPS | 18.6% | 16.2% | 11.9% | −12.8% | −26.8% | |||||
| 18-24 | SimSmoke | 24.2% | 19.2% | 16.7% | 14.2% | −20.5% | −13.2% | 42.9% | −41.4% | |
| TUS-CPS | 24.2% | 19.3% | 8.4% | −20.3% | −56.2% | |||||
| 25-44 | SimSmoke | 23.3% | 19.5% | 13.9% | 11.9% | −16.4% | −28.5% | 1.3% | −48.9% | |
| TUS-CPS | 23.3% | 19.5% | 13.7% | −16.3% | −29.8% | |||||
| 45-64 | SimSmoke | 19.3% | 18.3% | 16.3% | 14.6% | −5.3% | −10.5% | 5.0% | −24.2% | |
| TUS-CPS | 19.3% | 18.3% | 15.4% | −5.3% | −15.5% | |||||
| 65 and above | SimSmoke | 8.3% | 7.8% | 8.3% | 8.5% | −6.6% | 6.0% | 20.5% | 2.2% | |
| TUS-CPS | 8.3% | 7.8% | 6.7% | −6.5% | −14.5% |
Table 3.
Smoking prevalence of NHB adults and percent changes in SimSmoke and TUS-CPS, by age and sex, 2006-2023.
| Sex | Ages | Sources | 2006 | 2010 | 2018 | 2023 | % change 2006-2010 | % change 2010-2018 | Difference % change 2010- 2018 | % change 2006-2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Male | 18 and above | SimSmoke | 21.2% | 19.4% | 17.2% | 15.9% | −8.5% | −11.3% | 10.4% | −25.2% |
| TUS-CPS | 21.3% | 19.5% | 15.3% | −8.4% | −21.7% | |||||
| 18-24 | SimSmoke | 18.5% | 13.8% | 11.9% | 10.1% | −25.3% | −13.7% | 15.2% | −45.3% | |
| TUS-CPS | 18.5% | 13.8% | 9.8% | −25.3% | −28.9% | |||||
| 25-44 | SimSmoke | 20.4% | 19.2% | 17.3% | 16.2% | −6.2% | −9.9% | 8.1% | −20.7% | |
| TUS-CPS | 20.4% | 19.1% | 15.7% | −6.3% | −18.0% | |||||
| 45-64 | SimSmoke | 26.2% | 25.1% | 21.3% | 19.3% | −4.0% | −15.3% | 14.7% | −26.3% | |
| TUS-CPS | 26.2% | 25.1% | 17.6% | −3.9% | −30.0% | |||||
| 65 and above | SimSmoke | 13.8% | 12.5% | 13.8% | 13.8% | −9.2% | 10.6% | 8.4% | 0.5% | |
| TUS-CPS | 13.8% | 12.5% | 12.8% | −9.2% | 2.2% | |||||
| Female | 18 and above | SimSmoke | 14.9% | 13.0% | 10.7% | 9.6% | −12.8% | −17.6% | 1.3% | −35.8% |
| TUS-CPS | 15.0% | 13.0% | 10.6% | −12.9% | −18.9% | |||||
| 18-24 | SimSmoke | 12.1% | 8.1% | 6.6% | 5.6% | −32.6% | −18.6% | 14.4% | −53.6% | |
| TUS-CPS | 12.1% | 8.1% | 5.4% | −32.9% | −33.0% | |||||
| 25-44 | SimSmoke | 14.6% | 13.7% | 11.2% | 10.1% | −6.4% | −17.8% | 6.3% | −30.9% | |
| TUS-CPS | 14.6% | 13.7% | 10.4% | −6.4% | −24.1% | |||||
| 45-64 | SimSmoke | 19.9% | 16.8% | 12.7% | 10.7% | −15.5% | −24.2% | −3.8% | −46.0% | |
| TUS-CPS | 19.9% | 16.8% | 13.4% | −15.6% | −20.4% | |||||
| 65 and above | SimSmoke | 7.2% | 7.5% | 8.9% | 9.2% | 3.9% | 17.7% | 0.6% | 27.2% | |
| TUS-CPS | 7.2% | 7.5% | 8.8% | 3.9% | 17.0% |
Table 4.
Smoking prevalence of Hispanic adults and percent changes in SimSmoke and TUS-CPS, by age and sex, 2006-2023.
| Sex | Ages | Sources | 2006 | 2010 | 2018 | 2023 | % change 2006-2010 | % change 2010-2018 | Difference % change 2010-2018 | % change 2006-2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Male |
|
SimSmoke | 16.2% | 13.6% | 10.7% | 9.3% | −16.0% | −21.1% | 2.1% | −42.6% |
| TUS-CPS | 16.3% | 13.9% | 10.7% | −14.4% | −23.2% | |||||
| 18-24 | SimSmoke | 14.5% | 12.3% | 11.3% | 9.7% | −14.9% | −7.9% | 42.8% | −33.2% | |
| TUS-CPS | 14.5% | 14.0% | 6.9% | −3.0% | −50.6% | |||||
| 25-44 | SimSmoke | 16.9% | 14.0% | 10.7% | 9.5% | −17.3% | −23.4% | −4.9% | −43.8% | |
| TUS-CPS | 16.9% | 14.0% | 11.4% | −17.3% | −18.5% | |||||
| 45-64 | SimSmoke | 18.2% | 15.3% | 11.0% | 9.2% | −16.4% | −27.7% | −13.3% | −49.5% | |
| TUS-CPS | 18.2% | 15.2% | 13.1% | −16.4% | −14.3% | |||||
| 65 and above | SimSmoke | 9.1% | 8.7% | 8.9% | 8.3% | −4.7% | 2.5% | 23.3% | −8.8% | |
| TUS-CPS | 9.1% | 8.7% | 6.9% | −4.6% | −20.7% | |||||
| Female | 18 and above | SimSmoke | 9.1% | 7.9% | 6.2% | 5.3% | −13.0% | −21.9% | 20.5% | −41.8% |
| TUS-CPS | 9.1% | 7.8% | 4.5% | −13.9% | −42.4% | |||||
| 18-24 | SimSmoke | 8.1% | 6.8% | 5.7% | 4.9% | −15.4% | −15.7% | 51.6% | −39.0% | |
| TUS-CPS | 8.1% | 6.8% | 2.2% | −15.4% | −67.3% | |||||
| 25-44 | SimSmoke | 9.0% | 8.0% | 6.1% | 5.2% | −11.4% | −23.9% | 16.2% | −42.6% | |
| TUS-CPS | 9.0% | 8.0% | 4.8% | −11.3% | −40.2% | |||||
| 45-64 | SimSmoke | 11.4% | 9.7% | 7.3% | 6.1% | −14.9% | −24.7% | 15.0% | −46.0% | |
| TUS-CPS | 11.4% | 9.7% | 5.8% | −15.0% | −39.6% | |||||
| 65 and above | SimSmoke | 5.2% | 4.6% | 4.4% | 4.3% | −12.0% | −3.5% | 5.4% | −17.7% | |
| TUS-CPS | 5.2% | 3.9% | 3.6% | −23.8% | −8.9% |
For ages 18-24, 2006 male (female) smoking prevalence was 27.1% (24.2%) NHW, 18.5% (12.1%) for NHB, and 14.5% (8.1%) Hispanic adults, with respective 2006-2023 smoking relative reductions of 33.0% (41.4%), 45.3% (53.6%), and 33.2% (39.0%). For ages 25-44, 2006 smoking prevalence was 25.7% (23.3%) for NHW, 20.4% (14.6%) for NHB, and 16.9% (14.9%) for Hispanic adults, with respective relative reductions of 35.2% (48.9%), 20.6% (30.9%), and 43.8% (42.6%). For ages 45-64, NHB males and females had the highest 2006 prevalence, while NHB males had the least decline, but females showed a rapid decline by 2023. However, NHB females ages 65+ had mid-level prevalence and a relative increase of 27.2%.
Thus, for most age groups, NHB males had a lower initial prevalence than NHW males but showed the least decline from 2006 to 2023, while Hispanic males had the lowest prevalence and greatest decline. NHB females also generally had a lower 2006 prevalence but similar declines as NHW females, while Hispanic females generally had the lowest prevalence and similar declines to NHW females.
Comparison of relative reductions in smoking prevalence from SimSmoke and TUS-CPS
Tables 2-4 also compare SimSmoke smoking prevalence projections and relative changes from 2010 to 2018 by age, sex, and race/ethnicity to TUS-CPS estimates.
For age 18+ NHW males (females), TUS-CPS estimates projected a 10.2% (9.3%) greater absolute decline in actual prevalence than predicted by SimSmoke. For NHB males (females) age 18+, TUS-CPS showed a 10.4% (1.3%) greater absolute decline compared to SimSmoke. Hispanic smoking prevalence showed a 2.1% (20.5%) greater absolute decline than SimSmoke.
For ages 18-24, the difference in smoking prevalence relative reductions between Sim-Smoke and TUS-CPS was 48.2% (42.8%) for NHW, compared to 15.2% (14.4%) for NHB, and 42.8% (51.6%) for Hispanic males (females). For ages 25-44, the difference between SimSmoke and TUS-CPS was 10.5% (1.3%) for NHW, 8.1% (6.3%) for NHB, and −4.9% (16.2%) for Hispanic males (females). For ages 45-64, the difference was 0.2% (5.0%) NHW, 14.7% (−3.8%) for NHB, and −13.3% (15.0%) for Hispanic males (females). For ages 65+, the difference was 7.3% (20.5%) for NHW, 8.4% (0.5%) for NHB, and 23.3% (5.4%) for Hispanic males (females).
SimSmoke generally projected smaller relative reductions in smoking prevalence than TUS-CPS, especially for ages 18-24. The relative differences varied at other ages. Notably, NHB adults generally showed less relative reduction than NHW and Hispanic adults.
The effect of policies implemented through 2023
As shown in Tables 5-7, the impact of a particular policy or group of policies was estimated by comparing smoking prevalence with policies implemented to a counterfactual with no new policies implemented after 2006.
Table 5.
Smoking prevalence, smoking-attributable deaths, and averted deaths for both sexes predicted by SimSmoke for NHW adults in different policy scenarios, 2006-2060.
| Adult smoking prevalence | 2006 | 2023 | 2060 | Relative change by 2023 a | Relative change by 2060 a |
| No policies | 20.3% | 15.2% | 11.0% | – | – |
| All policies implemented | 20.3% | 12.8% | 7.2% | −15.4% | −34.4% |
| Price only | 20.3% | 14.2% | 9.7% | −6.5% | −11.4% |
| Smoke-free air only | 20.3% | 14.4% | 10.3% | −4.7% | −5.9% |
| Media campaign only | 20.3% | 15.2% | 11.0% | 0.1% | 0.4% |
| Cessation treatment only | 20.3% | 14.9% | 10.8% | −1.6% | −2.0% |
| Marketing restrictions only | 20.3% | 15.1% | 10.9% | −0.7% | −0.9% |
| Youth access ban only | 20.3% | 15.2% | 11.0% | −0.1% | −0.2% |
| T21 only | 20.3% | 14.7% | 8.9% | −3.1% | −18.9% |
| Total smoking-attributable deaths | 2006 | 2023 | 2060 | Cumulative 2006-2023 b | Cumulative 2006-2060 b |
| No policies | 371 732 | 286 241 | 160 991 | 5 517 332 | 14 354 062 |
| All policies implemented | 371 732 | 274 344 | 140 058 | 5 430 437 | 13 574 311 |
| Price only | 371 732 | 281 961 | 151 994 | 5 483 577 | 14 055 561 |
| Smoke-free air only | 371 732 | 280 464 | 154 497 | 5 476 595 | 14 030 814 |
| Media campaign only | 371 732 | 286 347 | 161 315 | 5 518 063 | 14 361 011 |
| Cessation treatment only | 371 732 | 284 498 | 158 135 | 5 506 678 | 14 220 789 |
| Marketing restrictions only | 371 732 | 285 459 | 160 081 | 5 511 613 | 14 310 590 |
| Youth access ban only | 371 732 | 286 241 | 160 921 | 5 517 332 | 14 353 356 |
| T21 only | 371 732 | 286 241 | 157 239 | 5 517 332 | 14 322 332 |
| Total SADs averted deaths | 2006 | 2023 | 2060 | Cumulative 2006-2023 b | Cumulative 2006-2060 b |
| All policies implemented | 0 | 11 896 | 20 933 | 86 895 | 779 751 |
| Price only | 0 | 4279 | 8996 | 33 756 | 298 501 |
| Smoke-free air only | 0 | 5777 | 6493 | 40 737 | 323 248 |
| Media campaign only | 0 | −107 | −325 | −731 | −6950 |
| Cessation treatment only | 0 | 1742 | 2855 | 10 655 | 133 273 |
| Marketing restrictions only | 0 | 782 | 909 | 5719 | 43 472 |
| Youth access ban only | 0 | 0 | 69 | 0 | 706 |
| T21 only | 0 | 0 | 3751 | 0 | 31 730 |
Relative changes in smoking prevalence by sex in 2023 and 2060 from scenario with overall/individual policy changes compared with a scenario with policies remaining constant at 2006 levels.
Sum of smoking-attributable deaths/sum of averted deaths for both sexes in 2006-2023 and 2006-2060.
Table 6.
Smoking prevalence, smoking-attributable deaths, and averted deaths for both sexes predicted by SimSmoke for NHB adults in different policy scenarios, 2006-2060.
| Adult smoking prevalence | 2006 | 2023 | 2060 | Relative change by 2023 a | Relative change by 2060 a |
| No policies | 18.1% | 15.0% | 11.2% | – | – |
| All policies implemented | 18.1% | 12.4% | 7.1% | −17.3% | −37.2% |
| Price only | 18.1% | 13.4% | 9.1% | −10.9% | −19.1% |
| Smoke-free air only | 18.1% | 14.4% | 10.8% | −3.9% | −4.4% |
| Media campaign only | 18.1% | 15.0% | 11.3% | 0.0% | 0.3% |
| Cessation treatment only | 18.1% | 14.9% | 11.2% | −0.8% | −0.5% |
| Marketing restrictions only | 18.1% | 14.9% | 11.2% | −0.6% | −0.7% |
| Youth access ban age 18 | 18.1% | 15.0% | 11.2% | −0.1% | −0.2% |
| T21 only | 18.1% | 14.7% | 9.3% | −2.4% | −17.6% |
| Total smoking-attributable deaths | 2006 | 2023 | 2060 | Cumulative 2006-2023 b | Cumulative 2006-2060 b |
| No policies | 55 959 | 52 245 | 37 248 | 920 315 | 2 625 783 |
| All policies implemented | 55 959 | 49 134 | 29 545 | 896 934 | 2 399 262 |
| Price only | 55 959 | 50 594 | 32 357 | 907 246 | 2 491 033 |
| Smoke-free air only | 55 959 | 51 056 | 35 759 | 911 930 | 2 560 011 |
| Media campaign only | 55 959 | 52 238 | 37 292 | 920 325 | 2 625 234 |
| Cessation treatment only | 55 959 | 51 965 | 36 851 | 918 531 | 2 606 908 |
| Marketing restrictions only | 55 959 | 52 082 | 37 031 | 919 112 | 2 616 813 |
| Youth access ban only | 55 959 | 52 245 | 37 224 | 920 315 | 2 625 539 |
| T21 only | 55 959 | 52 245 | 35 844 | 920 315 | 2 614 164 |
| Total averted deaths | 2006 | 2023 | 2060 | Cumulative 2006-2023 b | Cumulative 2006-2060 b |
| All policies implemented | 0 | 3111 | 7703 | 23 381 | 226 522 |
| Price only | 0 | 1651 | 4891 | 13 069 | 134 750 |
| Smoke-free air only | 0 | 1189 | 1489 | 8385 | 65 772 |
| Media campaign only | 0 | 7 | −44 | −10 | 549 |
| Cessation treatment only | 0 | 280 | 398 | 1784 | 18 876 |
| Marketing restrictions only | 0 | 163 | 217 | 1203 | 8971 |
| Youth access ban only | 0 | 0 | 24 | 0 | 244 |
| T21 only | 0 | 0 | 1404 | 0 | 11 620 |
Relative changes in smoking prevalence by sex in 2023 and 2060 from scenario with overall/individual policy changes compared with a scenario with policies remaining constant at 2006 levels.
Sum of smoking-attributable deaths/sum of averted deaths for both sexes in 2006-2023 and 2006-2060.
Table 7.
Smoking prevalence, smoking-attributable deaths, and averted deaths for both sexes predicted by SimSmoke for Hispanic adults in different policy scenarios, 2006-2060.
| Adult smoking prevalence | 2006 | 2023 | 2060 | Relative change by 2023 a | Relative change by 2060 a |
| No policies | 12.6% | 9.4% | 6.8% | – | – |
| All policies implemented | 12.6% | 7.3% | 3.8% | −22.6% | −43.4% |
| Price only | 12.6% | 8.1% | 5.3% | −14.1% | −22.2% |
| Smoke-free air only | 12.6% | 9.0% | 6.4% | −4.6% | −5.5% |
| Media campaign only | 12.6% | 9.4% | 6.8% | 0.2% | 0.4% |
| Cessation treatment only | 12.6% | 9.3% | 6.7% | −1.4% | −1.5% |
| Marketing restrictions only | 12.6% | 9.4% | 6.7% | −0.7% | −0.9% |
| Youth access ban only | 12.6% | 9.4% | 6.8% | −0.1% | −0.3% |
| T21 only | 12.6% | 9.1% | 5.3% | −3.9% | −21.0% |
| Total smoking-attributable deaths | 2006 | 2023 | 2060 | Cumulative 2006-2023 b | Cumulative 2006-2060 b |
| No policies | 21 645 | 27 429 | 31 601 | 403 898 | 1 612 497 |
| All policies implemented | 21 645 | 25 953 | 25 481 | 394 321 | 1 463 351 |
| Price only | 21 645 | 26 643 | 27 895 | 398 520 | 1 526 936 |
| Smoke-free air only | 21 645 | 26 886 | 30 287 | 400 570 | 1 569 594 |
| Media campaign only | 21 645 | 27 440 | 31 673 | 403 963 | 1 613 804 |
| Cessation treatment only | 21 645 | 27 261 | 31 037 | 402 990 | 1 593 951 |
| Marketing restrictions only | 21 645 | 27 355 | 31 413 | 403 427 | 1 606 669 |
| Youth access ban only | 21 645 | 27 429 | 31 574 | 403 898 | 1 612 239 |
| T21 only | 21 645 | 27 429 | 30 497 | 403 898 | 1 603 419 |
| Total averted deaths | 2006 | 2023 | 2060 | Cumulative 2006-2023 b | Cumulative 2006-2060 b |
| All policies implemented | 0 | 1476 | 6120 | 9577 | 149 146 |
| Price only | 0 | 787 | 3706 | 5378 | 85 561 |
| Smoke-free air only | 0 | 543 | 1313 | 3328 | 42 902 |
| Media campaign only | 0 | −11 | −72 | −65 | −1307 |
| Cessation treatment only | 0 | 168 | 564 | 908 | 18 545 |
| Marketing restrictions only | 0 | 74 | 188 | 471 | 5828 |
| Youth access ban only | 0 | 0 | 26 | 0 | 258 |
| T21 only | 0 | 0 | 1104 | 0 | 9078 |
Relative changes in smoking prevalence by sex in 2023 and 2060 from scenario with overall/individual policy changes compared with a scenario with policies remaining constant at 2006 levels.
Sum of smoking-attributable deaths/sum of averted deaths for both sexes in 2006-2023 and 2006-2060.
Compared with the counterfactual with no new policies implemented after 2006, SimSmoke projected that 2023 smoking rates with all policies were lower by 15.4% in relative terms for NHW, 17.3% for NHB, and 22.6% for Hispanic adults. By 2060, the relative impact on smoking prevalence increased to a 34.4%, 37.2%, and 43.4% decline for each respective group, since policies continued to reduce smoking rates through increased cessation and reduced initiation.
Much of the reduction in smoking prevalence was due to inflation-adjusted price increases ($4.95 in 2006 to $6.64 in 2023), which alone were predicted to reduce NHW, NHB, and Hispanic smoking prevalence in relative terms by 6%, 11%, and 14% by 2023 increasing to 11%, 19%, and 22% by 2060, averting 298,501, 134,750 and 85,561 SADs from 2006 to 2060. The differential impacts were primarily due to different price elasticities by racial/ethnic group (see Appendix S6 for impacts when assuming the same price elasticities).
Among other policies, most restrictions were implemented since 2006 (except media campaigns with negligible impacts) with the smallest impacts on NHB relative to NHW and Hispanic adults. Relative reductions by 2023 (2026) from Tobacco 21 were 2.4%-3.9% (17.6%-21.0%), from smoke-free air laws were 3.9%-4.7% (4.4%-5.9%), from cessation treatment were 0.8%-1.6% (0.5%-2.0%), and from marketing restrictions were 0.6%-0.7% (0.7%-0.9%).
Projected SADs and LYLs
Tables 5-7 also show SADS. With the policies implemented from 2006 through 2023 and maintained through 2060, SADs for both sexes combined decreased from 371,732 in 2006 to 274,344 in 2023 and 140,058 in 2060 for NHW adults, and from 55,959 in 2006 to 49,134 in 2023 and 29,545 in 2060 for NHB adults. However, SADs among Hispanic adults increased from 21,645 in 2006 to 25,953 in 2023 and then increased through 2039 with subsequent declines to 25,481 in 2060. From 2006 to 2060, SADs were 13.6 million for NHW, 2.4 million for NHB, and 1.5 million for Hispanic adults.
As a result of all policies, the total SADs averted from 2006 to 2060 were 779,751 for NHW, 226,522 for NHB, and 149,146 for Hispanic adults. As shown per thousand adults in Table 8, NHB adults faced the greatest health impact (2.7 SADs and 44.8 LYLs), followed by NHW (2.5 SADs and 38.9 LYLs) and Hispanic (1.1 SADs and 20.5 LYLs) adults.
Table 8.
Smoking-attributable deaths (SADs) and life-years lost (LYL) per thousand people at ages 40+ among NHW, NHB, and Hispanic populations, both male and females, in 2022.
| NHW male and female | NHB male and female | Hispanic male and female | |
|---|---|---|---|
| 2023 Smoking-attributable deaths in thousands | 274.3 (165.2, 109.1) | 49.5 (32.1, 17.4) | 26.0 (17.9, 8.0) |
| 2023 Life-years lost (LYLs) in thousands | 4284 (2577, 1708) | 834 (534, 300) | 482 (341, 141) |
| SADs per thousand people (with SADs in thousands and age 40+ population in millions) | 2.5 (3.1, 1.9) | 2.7 (3.9, 1.7) | 1.1 (1.5, 0.7) |
| LYLs per thousand people (with LYLs in thousands and age 40+ population in millions) | 38.9 (48.6, 29.9) | 44.8 (64.3, 29.1) | 20.5 (29.1, 11.9) |
Discussion
The separate US SimSmoke models for NHW, NHB, and Hispanic adults indicate major differences in smoking trends and SADs among NHW, NHB, and Hispanic adults, with NHB males having the highest smoking prevalence in 2023 and experiencing the smallest decline in smoking prevalence from 2006 to 2023. The results also indicate important differences in the impact of tobacco control policies, with large disparities among NHB compared to NHW and Hispanic adults. These findings suggest the need for policies that target specific racial/ethnic groups, particularly the higher NHB smoking prevalence and the associated health impacts. Past policy impacts indicate that higher taxes have been particularly effective.
Our results are broadly consistent with age-period cohort analyses of racial/ethnic groups by Meza et al.3 They found that NHB initiation historically has been lower than that of NHWs, with more rapid decreases since the 1970 birth cohort. Similarly, our study indicates that NHB initiation rates are about 40%-70% for males and 20%-60% for females compared to NHW initiation rates. Like our study, Meza et al. also found that cessation probabilities were similar among NHW and Hispanic adults but lower for NHB adults. Across cohorts, they observed that smoking prevalence among NHB populations, particularly males, was lower than among NHW populations at younger ages but higher at older ages. An important difference is that Meza et al. allow for cohort differences among recent generations, thereby incorporating potential recent trends, while our analysis explicitly incorporates recent policies.
Our results for recent years are more tentative due to differences in the 2018 model predictions and the 2018 TUS-CPS estimates. However, as previously applied to the United States,87 England,100 and Canada,101 the variation in predictions shows the potential impact of changes in ENDS and other omitted factors. While our results indicate a relatively large impact of these factors, especially for male and female NHW adult smoking prevalence, the results varied considerably by age, sex, and race/ethnicity. These findings suggest the need to better understand the impact of non-cigarette use and related policies in recent years, particularly for adults ages 18-24.113,114
In addition to ENDS, the role of smokeless tobacco115,116 and non-premium cigar use, including blunts (especially by NHB adults)5,117,118 merit consideration. Studies exploring the reactions of adults who use cigars to a hypothetical cigar flavor ban suggest that adults who use blunts may be less likely to quit cigars (blunts), and those who quit tend to switch to cannabis products.117,118 Consequently, blunt use may depend on local cannabis laws; for example, the market share of a popular Swisher cigarillo brand used for blunts was higher in areas that legalized cannabis in the United States.119,120 Further research is needed on racial/ethnic variations in cigar use and the impact of cannabis laws in conjunction with tobacco control laws.
Our results are subject to additional limitations. First, the projected racial/ethnic differences depend on the structure of the model itself, which depends on the initiation and cessation rates by race/ethnicity and failure to incorporate changes in behavior by recent cohorts, eg, due to changing product availability and use patterns. Second, the models do not consider deaths due to second-hand smoke or the impact of the COVID-19 pandemic. While studies indicate immediate impacts of COVID-19 on smoking behaviors by race/ethnicity,121,122 information on long-term impacts is limited, especially as they apply to racial/ethnic groups. We implicitly assume that the pandemic’s short-term impacts are temporary and trends revert to their pre-pandemic levels, but further research is warranted on long-term impacts by race/ethnicity.
Third, while having the greatest policy impact, price/tax is the only policy modeled with differential impacts by racial/ethnic group. Due to the limited information on differential racial/ethnic impacts, we did not distinguish racial/ethnic policy effects for smoke-free air laws, mass media campaigns, marketing restrictions, cessation treatments, and youth access policies. While we did not find that other policies had well-supported differential effects by race/ethnicity, one review17 indicated evidence of different impacts of cessation treatment policy due to the more limited access to treatments and a lack of targeting treatments to minority populations.106,108,109,123 In addition, studies suggest that Tobacco 21 laws are less well enforced in areas with minority populations.124-126 Further study is needed on differential tobacco-control policy impacts by race/ethnicity.
Fourth, trends in smoking prevalence and policy impacts may differ by socioeconomic status, geographic location within the United States, and variations within the NHW, NHB and Hispanic populations. In focusing on racial/ethnic variations, we do not distinguish the role of socioeconomic status or geography (eg, different locations in the United States) on smoking trends and policy impacts in order to reduce the complexity of the model. However, socioeconomic status (eg, the separate vs. intersectional impacts of socioeconomic status with race/ethnicity)66,116 and geographical location127,128 may differentially affect smoking trends and the impact of policies on racial/ethnic minority groups. Smoking prevalence and policy impacts may also vary within different segments of NHW, NHB and especially the Hispanic (eg, differences in Mexican vs. Puerto Rican smoking patterns)129-131 populations, but sample size restrictions and the lack of information on differential policy impacts limit the ability to distinguish any differences among these populations. Further research is warranted on differential impacts of socioeconomic relative to racial/ethnic, geographic, and sub-population variations.
Finally, while we have focused on policy impacts implemented via government, the cigarette industry may influence smoking trends and the implementation and impact of policies through lobbying132 and product marketing (via differential pricing and promotion through media and other outlets) to different racial/ethnic groups.133,134 These pathways of influence are complex and not incorporated in the model but merit further research.
Our paper provides the first estimates of expected future trends in smoking and health outcomes and the impact of multiple tobacco control policies on racial/ethnic disparities in smoking and SADs. Following Occam’s razor, important simplifications were made in developing the model, in order to focus on race/ethnicity using measures and policy effect sizes that are currently robust. Thereby, the models provide a systematic approach to identifying the information needed to understand the complexities associated with health inequities. Viewing modeling as an ongoing process, future extensions of the model135 will focus on the limitations highlighted above, especially the interactions between socioeconomic status and racial/ethnic identity, and the role of cigar and ENDS use by race/ethnicity. As we gain a better understanding of these and other factors, each of the racial/ethnic models will be updated, calibrated, and validated to reflect changes in use patterns and trends as influenced by policies.
Conclusions
Our analyses suggest large differences in the levels and rates of decline in NHW, NHB, and Hispanic smoking prevalence, indicating a widening of smoking-related health disparities. The variation in trends was partially related to the differential impacts of policies on racial/ethnic groups. This information can be used to inform additional tobacco control efforts to reduce disparities and improve health equity.
Supplementary Material
Contributor Information
David T Levy, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States.
James H Buszkiewicz, Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, United States.
Zhe Yuan, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States.
Yameng Li, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States.
Rafael Meza, Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Nancy L Fleischer, Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, United States.
Author contributions
David T. Levy (Conceptualization, Formal analysis, Validation, Writing—review & editing), James H. Buszkiewicz (Methodology, Writing—original draft, Writing—review & editing), Zhe Yuan (Methodology, Writing—review & editing), Yameng Li (Methodology, Writing—original draft, Writing—review & editing), Rafael Meza (Methodology, Writing—original draft, Writing—review & editing), and Nancy L. Fleischer (Funding acquisition, Methodology, Writing—original draft, Writing—review & editing).
Supplementary material
Supplementary material is available at Journal of the National Cancer Institute Monographs online.
Funding
This research was supported by National Cancer Institute of the National Institutes of Health (grants nos. R37CA214787 and 5U01CA152956). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Some of the authors were paid contributors to a Surgeon General’s Report and the corresponding author received an honorarium for their contribution to this special issue.
Monograph sponsorship
This article appears as part of the monograph, “Continued Impact of the Use of Commercial Tobacco Products on Health Disparities in the U.S.,” sponsored by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Conflicts of interest
The authors declare no conflicts of interest.
Data availability
All data used in this study are publicly available and will be provided to others upon reasonable request.
References
- 1. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Reports of the surgeon general. In: Samet JM, Pechacek TF, Norman LA, Taylor PL, eds. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention (US; ); 2014:1-953. [PubMed] [Google Scholar]
- 2. Cornelius ME, Loretan CG, Jamal A, et al. Tobacco product use among adults–United States, 2021. Morb Mortal Wkly Rep. 2023;72:475-483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Meza R, Cao P, Jeon J, et al. Patterns of birth cohort–specific smoking histories by race and ethnicity in the U.S. Am J Prev Med. 2023;64:S11-S21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Jeon J, Inoue-Choi M, Mok Y, et al. Mortality relative risks by smoking, race/ethnicity, and education. Am J Prev Med. 2023;64:S53-S62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Jeon J, Mok Y, Meza R. Cross-sectional patterns and longitudinal transitions of premium and non-premium cigar use in the United States. Nicotine Tob Res. 2023;25:S16-S23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12-49. [DOI] [PubMed] [Google Scholar]
- 7. Wilson LM, Avila Tang E, Chander G, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Environ Public Health. 2012;2012:961724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Hill S, Amos A, Clifford D, Platt S. Impact of tobacco control interventions on socioeconomic inequalities in smoking: review of the evidence. Tob Control. 2014;23:e89-e97. [DOI] [PubMed] [Google Scholar]
- 9. Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012;1248:107-123. [DOI] [PubMed] [Google Scholar]
- 10. Main C, Thomas S, Ogilvie D, et al. Population tobacco control interventions and their effects on social inequalities in smoking: placing an equity lens on existing systematic reviews. BMC Public Health. 2008;8:178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Lantz PM, Jacobson PD, Warner KE, et al. Investing in youth tobacco control: a review of smoking prevention and control strategies. Tob Control. 2000;9:47-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Thomas S, Fayter D, Misso K, et al. Population tobacco control interventions and their effects on social inequalities in smoking: systematic review. Tob Control. 2008;17:230-237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Tauras JA. Differential impact of state tobacco control policies among race and ethnic groups. Addiction. 2007;102 Suppl 2:95-103. [DOI] [PubMed] [Google Scholar]
- 14. Brown T, Platt S, Amos A. Equity impact of interventions and policies to reduce smoking in youth: systematic review. Tob Control. 2014;23:e98-e105. [DOI] [PubMed] [Google Scholar]
- 15. Brown T, Platt S, Amos A. Equity impact of population-level interventions and policies to reduce smoking in adults: a systematic review. Drug Alcohol Depend. 2014;138:7-16. [DOI] [PubMed] [Google Scholar]
- 16. Greaves L, Johnson J, Bottorff J, et al. What are the effects of tobacco policies on vulnerable populations? A better practices review. Can J Public Health. 2006;97:310-315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Smith CE, Hill SE, Amos A. Impact of population tobacco control interventions on socioeconomic inequalities in smoking: a systematic review and appraisal of future research directions. Tob Control. 2020;30:e87-e95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Abouk R, De P, Pesko M. Estimating the Effects of Tobacco-21 on Youth Tobacco Use and Sales. SSRN; 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Colston DC, Xie Y, Patrick ME, et al. Tobacco 21 laws may reduce smoking and tobacco-related health disparities among youth in the U.S. Prev Med Rep. 2022;27:101762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Agaku IT, Nkosi L, Agaku QD, Gwar J, Tsafa T. A rapid evaluation of the US Federal Tobacco 21 (T21) law and lessons from statewide T21 policies: findings from population-level surveys. Prev Chronic Dis. 2022;19:E29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Bryan C, Hansen B, McNichols D, Sabia JJ. Do State Tobacco 21 Laws Work? National Bureau of Economic Research; 2021. [Google Scholar]
- 22. Friedman AS, Buckell J, Sindelar JL. Tobacco-21 laws and young adult smoking: quasi-experimental evidence. Addiction. 2019;114:1816-1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Friedman AS, Wu RJ. Do local Tobacco-21 laws reduce smoking among 18 to 20 year-olds? Nicotine Tob Res. 2020;22:1195-1201. [DOI] [PubMed] [Google Scholar]
- 24. Schneider SK, Buka SL, Dash K, Winickoff JP, O’Donnell L. Community reductions in youth smoking after raising the minimum tobacco sales age to 21. Tob Control. 2016;25:355-359. [DOI] [PubMed] [Google Scholar]
- 25. Wilhelm AK, Kingsbury JH, Eisenberg ME, Shyne M, Helgertz S, Borowsky IW. Local Tobacco 21 policies are associated with lower odds of tobacco use among adolescents. Nicotine Tob Res. 2022;24:478-483. [DOI] [PubMed] [Google Scholar]
- 26. Azagba S, Shan L, Latham K. County smoke-free laws and cigarette smoking among U.S. adults, 1995-2015. Am J Prev Med. 2020;58:97-106. [DOI] [PubMed] [Google Scholar]
- 27. Ballester LS, Auchincloss AH, Robinson LF, Mayne SL. Exploring impacts of taxes and hospitality bans on cigarette prices and smoking prevalence using a large dataset of cigarette prices at stores 2001-2011, USA. Int J Environ Res Public Health. 2017;14:318-332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. DeCicca P, McLeod L. Cigarette taxes and older adult smoking: evidence from recent large tax increases. J Health Econ. 2008;27:918-929. [DOI] [PubMed] [Google Scholar]
- 29. Dunbar MS, Nicosia N, Kilmer B. Estimating the impact of state cigarette tax rates on smoking behavior: addressing endogeneity using a natural experiment. Drug Alcohol Depend. 2021;225:108807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Dutra LM, Farrelly MC, Nonnemaker J, et al. Differential Relationship between tobacco control policies and U.S. adult current smoking by poverty. Int J Environ Res Public Health. 2019;16:4130-4145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Farrelly MC, Nonnemaker JM, Watson KA. The consequences of high cigarette excise taxes for low-income smokers. PLoS One. 2012;7:e43838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Keeler C, Max W, Yao T, Wang Y, Zhang X, Sung HY. Smoking behavior in low- and high-income adults immediately following California Proposition 56 tobacco tax increase. Am J Public Health. 2020;110:868-870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Keeler C, Wang Y, Max W, Yao T, Gu D, Sung HY. The Association of California’s Proposition 56 tobacco tax increase with smoking behavior across racial and ethnic groups and by income. Nicotine Tob Res. 2021;23:2091-2101. [DOI] [PubMed] [Google Scholar]
- 34. Le TTT, Jaffri MA. The association between smoking behaviors and prices and taxes per cigarette pack in the United States from 2000 through 2019. BMC Public Health. 2022;22:856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Mader EM, Lapin B, Cameron BJ, Carr TA, Morley CP. Update on performance in tobacco control: a longitudinal analysis of the impact of tobacco control policy and the US adult smoking rate, 2011-2013. J Public Health Manag Pract. 2016;22:E29-E35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Mayne SL, Auchincloss AH, Stehr MF, et al. Longitudinal associations of local cigarette prices and smoking bans with smoking behavior in the multi-ethnic study of atherosclerosis. Epidemiology. 2017;28:863-871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Mojtabai R, Riehm KE, Cohen JE, Alexander GC, Rutkow L. Clean indoor air laws, cigarette excise taxes, and smoking: results from the current population survey-tobacco use supplement, 2003-2011. Prev Med. 2019;126:105744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Morley CP, Pratte MA. State-level tobacco control and adult smoking rate in the United States: an ecological analysis of structural factors. J Public Health Manag Pract. 2013;19:E20-E27. [DOI] [PubMed] [Google Scholar]
- 39. Sharbaugh MS, Althouse AD, Thoma FW, Lee JS, Figueredo VM, Mulukutla SR. Impact of cigarette taxes on smoking prevalence from 2001-2015: a report using the Behavioral and Risk Factor Surveillance Survey (BRFSS). PLoS One. 2018;13:e0204416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Nesson E. The impact of tobacco control policies on adolescent smoking: comparing self-reports and biomarkers. Am J Health Econ. 2017;3:507-527. [Google Scholar]
- 41. Fleischer NL, Donahoe JT, McLeod MC, et al. Taxation reduces smoking but may not reduce smoking disparities in youth. Tob Control. 2021;30:264-272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Parks MJ, Patrick ME, Levy DT, Thrasher JF, Elliott MR, Fleischer NL. Tobacco taxation and its prospective impact on disparities in smoking initiation and progression among young adults. J Adolesc Health. 2021;68:765-772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Dahne J, Nahhas GJ, Wahlquist AE, Cummings KM, Carpenter MJ. State tobacco excise taxation, comprehensive smoke-free air laws, and tobacco control appropriations as predictors of smoking cessation success in the United States. J Publ Health Manag Pract. 2020;26:E1-E4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Christian WJ, Walker CJ, Huang B, Hahn EJ. Effect of local smoke-free ordinances on smoking prevalence in Kentucky, 2002-2009. South Med J. 2019;112:369-375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Emery S, Kim Y, Choi YK, Szczypka G, Wakefield M, Chaloupka FJ. The effects of smoking-related television advertising on smoking and intentions to quit among adults in the United States: 1999-2007. Am J Public Health. 2012;102:751-757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Fernander AF, Rayens MK, Adkins S, Hahn EJ. Local smoke-free public policies, quitline call rate, and smoking status in Kentucky. Am J Health Promot. 2014;29:123-126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Hahn EJ, Rayens MK, Butler KM, Zhang M, Durbin E, Steinke D. Smoke-free laws and adult smoking prevalence. Prev Med. 2008;47:206-209. [DOI] [PubMed] [Google Scholar]
- 48. Nguyen RH, Vater LB, Timsina LR, et al. Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence. PLoS One. 2021;16:e0250285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Farrelly MC, Loomis BR, Kuiper N, et al. Are tobacco control policies effective in reducing young adult smoking? J Adolesc Health. 2014;54:481-486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Hawkins SS, Bach N, Baum CF. Impact of tobacco control policies on adolescent smoking. J Adolesc Health. 2016;58:679-685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Huang J, Chaloupka FJ. The Impact of the 2009 Federal Tobacco Excise Tax Increase on Youth Tobacco Use. National Bureau of Economic Research; 2012. [Google Scholar]
- 52. Titus AR, Xie Y, Colston DC, et al. Smoke-free laws and disparities in youth smoking in the U.S., 2001-2018. Am J Prev Med. 2021;61:841-851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Song AV, Dutra LM, Neilands TB, Glantz SA. Association of smoke-free laws with lower percentages of new and current smokers among adolescents and young adults: an 11-year longitudinal study. JAMA Pediatr. 2015;169:e152285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Titus AR, Xie Y, Thrasher JF, et al. A longitudinal analysis of smoke-free laws and smoking initiation disparities among young adults in the United States. Addiction. 2022;117:730-738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Schillo BA, Keller PA, Betzner AE, Greenseid L, Christenson M, Luxenberg MG. Minnesota’s smokefree policies: impact on cessation program participants. Am J Prev Med. 2012;43:S171-S178. [DOI] [PubMed] [Google Scholar]
- 56. Titus AR, Thrasher JF, Gamarel KE, Emery SL, Elliott MR, Fleischer NL. Televised anti-tobacco media and smoking outcomes among heterosexual and sexual minority adults in the United States. Health Educ Behav 2023;50:234-239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Nonnemaker JM, Dench D, Homsi G, MacMonegle A, Duke J. The effect of exposure to media campaign messages on adult cessation. Addict Behav. 2015;49:13-19. [DOI] [PubMed] [Google Scholar]
- 58. Colston DC, Cho B, Thrasher JF, et al. Anti-smoking media campaigns and disparities in smoking cessation in the United States, 2001-2015. Am J Health Promot. 2021;35:658-668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Duke JC, MacMonegle AJ, Nonnemaker JM, et al. Impact of the real cost media campaign on youth smoking initiation. Am J Prev Med. 2019;57:645-651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Farrelly MC, Duke JC, Nonnemaker J, et al. Association between the real cost media campaign and smoking initiation among youths—United States, 2014-2016. MMWR Morb Mortal Wkly Rep. 2017;66:47-50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Vallone DM, Perks SN, Pitzer L, et al. Evidence of the impact of a national anti-tobacco prevention campaign across demographic subgroups. Health Educ Res. 2022;36:412-421. [DOI] [PubMed] [Google Scholar]
- 62. Cavazos-Rehg PA, Krauss MJ, Sowles SJ, et al. Multiple levels of influence that impact youth tobacco use. Tob Regul Sci. 2016;2:106-122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Hair EC, Niederdeppe J, Rath JM, et al. Using aggregate temporal variation in Ad awareness to assess the effects of the truth® campaign on youth and young adult smoking behavior. J Health Commun. 2020;25:223-231. [DOI] [PubMed] [Google Scholar]
- 64. Colston DC, Xie Y, Thrasher JF, et al. Examining truth and state-sponsored media campaigns as a means of decreasing youth smoking and related disparities in the United States. Nicotine Tob Res. 2022;24:469-477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Slocum E, Xie Y, Colston DC, et al. Impact of the tips from former smokers anti-smoking media campaign on youth smoking behaviors and anti-tobacco attitudes. Nicotine Tob Res. 2022;24:1927-1936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Mills SD, Golden SD, O'Leary MC, Logan P, Hassmiller Lich K. Using systems science to advance health equity in tobacco control: a causal loop diagram of smoking. Tob Control. 2023;32:287-295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Grube JW, Lipperman-Kreda S, Garcia-Ramirez G, Paschall MJ, Abadi MH. California's Tobacco 21 minimum sales age law and adolescents' tobacco and nicotine use: differential associations among racial and ethnic groups. Tob Control 2022;31:e126-e133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Trapl E, Pike Moore S, Osborn C, et al. Evaluation of restrictions on tobacco sales to youth younger than 21 years in Cleveland, Ohio, area. JAMA Netw Open. 2022;5:e2222987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Abouk R, De PK, Pesko M. Estimating the Effects of Tobacco-21 on Youth Tobacco Use and Sales. SSRN; 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. MacLean JC, Kessler AS, Kenkel DS. Cigarette taxes and older adult smoking: evidence from the health and retirement study. Health Econ. 2016;25:424-438. [DOI] [PubMed] [Google Scholar]
- 71. Wang Y, Max W, Yao T, Keeler C, Sung HY. Differential price-responsiveness of smoking behaviors among non-Hispanic African Americans and non-Hispanic whites in the United States. Addiction. 2021;116:2859-2869. [DOI] [PubMed] [Google Scholar]
- 72. Yao T, Ong MK, Max W, et al. Responsiveness to cigarette prices by different racial/ethnic groups of US adults. Tob Control. 2018;27:301-309. [DOI] [PubMed] [Google Scholar]
- 73. Yu H, Engberg J, Scharf D. One size fits all? Disentangling the effects of tobacco taxes, laws, and control spending on adult subgroups in the United States. Subst Abus. 2019;40:87-94. [DOI] [PubMed] [Google Scholar]
- 74. Parks MJ, Patrick ME, Levy DT, Thrasher JF, Elliott MR, Fleischer NL. Cigarette pack price and its within-person association with smoking initiation, smoking progression, and disparities among young adults. Nicotine Tob Res. 2022;24:519-528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. van Hasselt M, Kruger J, Han B, et al. The relation between tobacco taxes and youth and young adult smoking: what happened following the 2009 U.S. federal tax increase on cigarettes? Addict Behav. 2015;45:104-109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Nonnemaker JM, Farrelly MC. Smoking initiation among youth: the role of cigarette excise taxes and prices by race/ethnicity and gender. J Health Econ. 2011;30:560-567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Carton TW, Darden M, Levendis J, Lee SH, Ricket I. Comprehensive indoor smoking bans and smoking prevalence: evidence from the BRFSS. Am J Health Econ. 2016;2:535-556. [Google Scholar]
- 78. Tauras JA, Huang J, Chaloupka FJ. Differential impact of tobacco control policies on youth sub-populations. Int J Environ Res Publ Health. 2013;10:4306-4322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Titus AR, Kalousova L, Meza R, et al. Smoke-free policies and smoking cessation in the United States, 2003-2015. Int J Environ Res Public Health. 2019;16:3200-3211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Flynn BS, Worden JK, Bunn JY, et al. Mass media interventions to reduce youth smoking prevalence. Am J Prev Med. 2010;39:53-62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Burns EK, Levinson AH. Reaching Spanish-speaking smokers: state-level evidence of untapped potential for QuitLine utilization. Am J Public Health. 2010;100(suppl 1):S165–S710.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Levy D, de Almeida LM, Szklo A. The Brazil SimSmoke policy simulation model: the effect of strong tobacco control policies on smoking prevalence and smoking-attributable deaths in a middle income nation. PLoS Med. 2012;9:e1001336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Levy D, Rodriguez-Buno RL, Hu TW, Moran AE. The potential effects of tobacco control in China: projections from the China SimSmoke simulation model. BMJ. 2014;348:G1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Levy DT, Borland R, Villanti AC, et al. The application of a decision-theoretic model to estimate the public health impact of vaporized nicotine product initiation in the United States. Nicotine Tob Res 2017;19:149-159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Levy DT, Meza R, Zhang Y, Holford TR. Gauging the effect of U.S. tobacco control policies from 1965 through 2014 using SimSmoke. Am J Prev Med. 2016;50:535-542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Levy DT, Mabry PL, Graham AL, Orleans CT, Abrams DB. Reaching healthy people 2010 by 2013: a SimSmoke simulation. Am J Prev Med. 2010;38:S373-81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Levy DT, Sanchez-Romero LM, Travis N, et al. US nicotine vaping product SimSmoke simulation model: the effect of vaping and tobacco control policies on smoking prevalence and smoking-attributable deaths. Int J Environ Res Public Health. 2021;18:4876-4897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Huang V, Head A, Hyseni L, et al. Identifying best modelling practices for tobacco control policy simulations: a systematic review and a novel quality assessment framework. Tob Control. 2023;32:589-598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Alexander LA, Trinidad DR, Sakuma KL, et al. Why we must continue to investigating menthol's role in the African American smoking paradox. Nicotine Tob Res. 2016;18(suppl 1):S91-S101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Holford TR, Levy DT, Meza R. Comparison of smoking history patterns among African American and white cohorts in the United States born 1890 to 1990. Nicotine Tob Res. 2016;18(suppl 1):S16-S29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Mendez D, Le TTT. Consequences of a match made in hell: the harm caused by menthol smoking to the African American population over 1980-2018. Tob Control. 2021;31:569-571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Levy DT, Pearson JL, Villanti AC, et al. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health. 2011;101:1236-1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Issabakhsh M, Meza R, Li Y, Yuan Z, Sanchez-Romero LM, Levy DT. Public health impact of a US menthol cigarette ban on the non-Hispanic black population: a simulation study. Tob Control. 2023;33:126-130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Levy DT, Meza R, Yuan Z, et al. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study. Tob Control. 2023;32:e37-e44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Feirman SP, Glasser AM, Rose S, et al. Computational models used to assess US tobacco control policies. Nicotine Tob Res. 2017;19:1257-1267. [DOI] [PubMed] [Google Scholar]
- 96. Singh A, Wilson N, Blakely T. Simulating future public health benefits of tobacco control interventions: a systematic review of models. Tob Control. 2020;30:460-470. [DOI] [PubMed] [Google Scholar]
- 97. Levy DT, Mays D, Yuan Z, Hammond D, Thrasher JF. Public health benefits from pictorial health warnings on US cigarette packs: a SimSmoke simulation. Tob Control. 2017;26:649-655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Levy DT, Nikolayev L, Mumford E. Recent trends in smoking and the role of public policies: results from the SimSmoke tobacco control policy simulation model. Addiction. 2005;100:1526-1536. [DOI] [PubMed] [Google Scholar]
- 99. Levy DT, Yuan Z, Li Y. The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use. BMC Public Health. 2018;18:696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Levy DT, Sánchez‐Romero LM, Li Y, et al. England SimSmoke: the impact of nicotine vaping on smoking prevalence and smoking‐attributable deaths in England. Addiction. 2021;116:1196-1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Levy DT, Cadham CJ, Yuan Z, Li Y, Gravely S, Cummings KM. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model. Can J Public Health. 2023;114:992-1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.U.S. Bureau of the Census. Projected net international migration by age, sex, race, and Hispanic origin: 2014 to 2060, US Census Bureau. Published 2016. Accessed December 15, 2016. https://www.census.gov/population/projections/data/national/2014/downloadablefiles.html; https://www.census.gov/data/datasets/2014/demo/popproj/2014-popproj.html
- 103. Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311:164-171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Rosenberg MA, Feuer EJ, Yu B, et al. Chapter 3: cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal. 2012; 32(suppl 1):S25-S38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Institute of Medicine. Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products. National Academy of Sciences; 2015. [PubMed] [Google Scholar]
- 106. Sakuma KK, Pierce JP, Fagan P, et al. Racial/ethnic disparities across indicators of cigarette smoking in the era of increased tobacco control, 1992-2019. Nicotine Tob Res. 2021;23:909-919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Trinidad DR, Perez-Stable EJ, White MM, Emery SL, Messer K. A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors. Am J Public Health. 2011;101:699-706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Trinidad DR, Xie B, Fagan P, et al. Disparities in the population distribution of African American and non-Hispanic White smokers along the quitting continuum. Health Educ Behav. 2015;42:742-751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. Alboksmaty A, Agaku IT, Odani S, Filippidis FT. Prevalence and determinants of cigarette smoking relapse among US adult smokers: a longitudinal study. BMJ Open. 2019;9:e031676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110. Caraballo RS, Kruger J, Asman K, et al. Relapse among the cigarette smokers: the CAR–IA longitudinal study—1985–2011. Addict Behav. 2014;39:101-106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Cook S, Curtis J, Buszkiewicz JH, Brouwer AF, Fleischer NL. Financial strain and smoking cessation and relapse among U.S. adults who smoke: a longitudinal cohort study. Am J Prev Med. 2024;68:464-471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Yi Z, Mayorga ME, Hassmiller Lich K, Pearson JL. Changes in cigarette smoking initiation, cessation, and relapse among U.S. adults: a comparison of two longitudinal samples. Tob Induc Dis. 2017;15:17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Boakye E, Osuji N, Erhabor J, et al. Assessment of patterns in e-cigarette use among adults in the US, 2017-2020. JAMA Netw Open. 2022;5:e2223266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Dai H, Leventhal AM. Prevalence of e-cigarette use among adults in the United States, 2014-2018. JAMA. 2019;322:1824-1827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Chang JT, Levy DT, Meza R. Trends and factors related to smokeless tobacco use in the United States. Nicotine Tob Res. 2016;18:1740-1748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Zavala-Arciniega L, Meza R, Hirschtick JL, Fleischer NL. Disparities in cigarette, e-cigarette, cigar, and smokeless tobacco use at the intersection of multiple social identities in the US adult population. Results from the tobacco use supplement to the current population survey 2018-2019 survey. Nicotine Tob Res. 2023;25:908-917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Pakdaman S, Broun A, Duarte DA, et al. Exploring the hypothetical impact of flavored cigar sales restrictions among black young adult cigar smokers: a semi-structured in-depth interview investigation. J Ethn Subst Abuse. 2022;23:501-519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118. Chen-Sankey J, Elhabashy M, Ajith A, et al. Correlates of behavior change intents in response to a hypothetical flavored cigar sales restriction among U.S. adult flavored cigar smokers. Prev Med. 2022;165:107128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119. Giovenco DP, Spillane TE, Mauro CM, Martins SS. Cigarillo sales in legalized marijuana markets in the U.S. Drug Alcohol Depend. 2018;185:347-350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120. Chu A, Chaiton M, Kaufman P, et al. Co-use, simultaneous use, and mixing of cannabis and tobacco: a cross-national comparison of Canada and the US by Cannabis Administration Type. Int J Environ Res Public Health. 2023;20:4206-4216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121. Gaffney A, Himmelstein DU, Woolhandler S. Smoking prevalence during the COVID-19 pandemic in the United States. Ann Am Thorac Soc. 2022;19:1065-1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122. Nagawa CS, Ito Fukunaga M, Faro JM, et al. Characterizing pandemic-related changes in smoking over time in a cohort of current and former smokers. Nicotine Tob Res. 2023;25:203-210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123. Avila JC, Sokolovsky AW, Nollen NL, Lee J, Schmid CH, Ahluwalia JS. The effect of race/ethnicity and adversities on smoking cessation among U.S. adult smokers. Addict Behav. 2022;131:107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124. Roberts ME, Klein EG, Ferketich AK, et al. Beyond strong enforcement: understanding the factors related to retailer compliance with Tobacco 21. Nicotine Tob Res. 2021;23:2084-2090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125. Dai H, Tamrakar N, Rathnayake N, Samson K. Geographical distribution and social determinants of Tobacco 21 policy adoption and retail inspections in the United States, 2015-2019. Tob Induc Dis. 2021;19:55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126. Jenkins C, Schwartz E, Onnen N, Craigmile PF, Roberts ME. Variations in tobacco retailer type across community characteristics: place matters. Prev Chronic Dis. 2022;19:E49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127. Fakunle DO, Curriero FC, Leaf PJ, Furr-Holden DM, Thorpe RJ. Black, white, or green? The effects of racial composition and socioeconomic status on neighborhood-level tobacco outlet density. Ethn Health. 2021;26:1012-1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128. Valiente R, Escobar F, Urtasun M, Franco M, Shortt NK, Sureda X. Tobacco retail environment and smoking: a systematic review of geographic exposure measures and implications for future studies. Nicotine Tob Res. 2021;23:1263-1273. [DOI] [PubMed] [Google Scholar]
- 129. Blanco L, Garcia R, Perez-Stable EJ, et al. National trends in smoking behaviors among Mexican, Puerto Rican, and Cuban men and women in the United States. Am J Public Health. 2014;104:896-903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130. Felicitas-Perkins JQ, Sakuma KK, Blanco L, et al. Smoking among Hispanic/Latino nationality groups and whites, comparisons between California and the United States. Nicotine Tob Res. 2018;20:1085-1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131. Kaplan RC, Bangdiwala SI, Barnhart JM, et al. Smoking among U.S. Hispanic/Latino adults: The Hispanic community health study/study of Latinos. Am J Prev Med. 2014;46:496-506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132. Saloojee Y, Dagli E. Tobacco industry tactics for resisting public policy on health. Bull World Health Organ. 2000;78:902-910. [PMC free article] [PubMed] [Google Scholar]
- 133. Levy D, Chaloupka F, Lindblom EN, et al. The US Cigarette Industry: an economic and marketing perspective. Tob Regul Sci. 2019;5:156-168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134. Levy DT, Liber AC, Cadham C, et al. Follow the money: a closer look at US tobacco industry marketing expenditures. Tob Control. 2023;32:575-582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135. Vander Woude CA, Buszkiewicz JH, Travis N, James LN, Fleischer NL. Tobacco control policies and sociodemographic disparities in cigarette smoking behaviors in the U.S.: a systematic review protocol. AJPM Focus. 2024;3:100256. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data used in this study are publicly available and will be provided to others upon reasonable request.
